Query Trends : Nectar Lifesciences

Query : I am holing 100 shares of Nectar Lifesciences @232. Was expecting the stock to move up after spectacular results. Should I continue to hold or should I sell it. Vikas G

Thebullishtrends: Nectar Lifesciences shares are trading at Rs.296. NecLife (Nectar Lifesciences Ltd.) was incorporated by Mr. Sanjiv Goyal, for manufacture of oral and sterile range of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). It has developed sustainable production systems to manufacture highest quality pharmaceutical products meeting diverse requirements of its customer base in over 45 countries worldwide.

Nectar is having strong growth story, infact Pharma bulk drug companies are not having great P/E s hence the stock is available with a low P/E. Nectar's second quarter results are very encouraging compared to last year the same period. Please hold this scrip and review your decission after March'08.